Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer
Status:
NOT_YET_RECRUITING
Trial end date:
2030-12-31
Target enrollment:
Participant gender:
Summary
Research Objective:To investigate the efficacy and safety of the "total neoadjuvant chemoradiotherapy combined with immunotherapy" regimen for the treatment of locally advanced rectal cancer with high-risk features for recurrence.
Study Design:A single-arm, multicenter clinical study.
Study Population: Patients with locally advanced rectal cancer presenting with high-risk features for local recurrence.
Phase:
PHASE2
Details
Lead Sponsor:
The First Affiliated Hospital of University of Science and Technology of China